Brief: First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial

June 5 (Reuters) - Imunon Inc  IMNN.O :
    * FIRST PARTICIPANTS VACCINATED IN IMUNON’S IMNN-101 PHASE 1
CLINICAL TRIAL

Source text for Eikon:  ID:nGNXbFDtky 
Further company coverage:  IMNN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Imunon

See all news